Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Risa Akizuki"'
Autor:
Ryohei Maruhashi, Shohei Hamada, Hiroaki Eguchi, Risa Akizuki, Takumi Furuta, Toshiyuki Matsunaga, Kenji Ichihara, Satoshi Endo, Akira Ikari
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
Scientific Reports
Scientific Reports
The aberrant expression of claudins (CLDNs), which are tight junctional proteins, is seen in various solid tumors, but the regulatory mechanisms and their pathophysiological role are not well understood. Both CLDN1 and CLDN11 were highly expressed in
Publikováno v:
Biological and Pharmaceutical Bulletin. 42:247-254
Abnormal expression of the tight junctional components claudins (CLDNs) is observed in various malignant tissues. We reported recently that CLDN18 expression is down-regulated in human lung adenocarcinoma tissues. In the present study, we investigate
Autor:
Haruka Nasako, Ayaka Ito, Risa Akizuki, Yuta Yoshino, Akira Ikari, Yui Takashina, Satoshi Endo, Hiroaki Eguchi, Toshiyuki Matsunaga
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 6582, p 6582 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 12
International Journal of Molecular Sciences
Volume 22
Issue 12
Claudin-2 (CLDN2), a tight junctional protein, is involved in the chemoresistance in a three-dimensional spheroid culture model of human lung adenocarcinoma A549 cells. However, the mechanism has not been fully clarified. We found that the knockdown
Autor:
Hiroaki Eguchi, Takumi Furuta, Satoshi Endo, Akira Ikari, Risa Akizuki, Ryohei Maruhashi, Toshiyuki Matsunaga, Mitsutoshi Tsukimoto
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Scientific Reports
Scientific Reports
Chemoresistance is a serious issue in the therapy of many cancers, but the molecular mechanism is little understood. The mRNA level of occludin (OCLN), a tight junctional protein, was increased in the cisplatin (CDDP), doxorubicin (DXR), 7-ethyl-10-h
Autor:
Akira Ikari, Hiroaki Eguchi, Risa Akizuki, Toshiyuki Matsunaga, Kazuki Kitabatake, Ryohei Maruhashi, Satoshi Endo, Mitsutoshi Tsukimoto, Takumi Furuta
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1865:769-780
Chemotherapy resistance is a major problem in the treatment of cancer, but the underlying mechanisms are not fully understood. We found that the expression levels of claudin-1 (CLDN1) and 3, tight junctional proteins, are upregulated in cisplatin (CD
Autor:
Saeko Taga, Satoshi Endo, Miki Okamoto, Akira Ikari, Risa Akizuki, Toshiyuki Matsunaga, Asami Hichino
Publikováno v:
Journal of Biological Chemistry. 292:2411-2421
Claudin-2 is highly expressed in lung adenocarcinoma tissues and increases proliferation in adenocarcinoma cells. The chemicals that reduce claudin-2 expression may have anti-cancer effects, but such therapeutic medicines have not been developed. We
Autor:
Yoshinobu Ishikawa, Toshiyuki Matsunaga, Tomohiro Asai, Akira Ikari, Haruka Nasako, Yui Takashina, Risa Akizuki, Mikako Shirouzu, Takehiro Shinoda, Satoshi Endo
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867:118642
Claudin-2 (CLDN2), a tight junctional protein, is involved in the chemoresistance in spheroid culture models of human lung adenocarcinoma A549 cells. However, there is no chemical which can improve the sensitivity to anticancer drugs. So far, we repo
Autor:
Risa Akizuki, Ryohei Maruhashi, Akira Ikari, Yasuhiro Yamazaki, Hideki Sakai, Toshiyuki Matsunaga, Tomonari Sato, Satoshi Endo, Masahiko Yamaguchi
Publikováno v:
Biochimica et biophysica acta. Molecular cell research. 1865(3)
Claudins, tight junctional proteins, regulate the paracellular permeability of ions and small molecules. Claudin-2 is highly expressed in human lung adenocarcinoma cells and is involved in the up-regulation of cell proliferation. However, the effect
Publikováno v:
Biochimica et biophysica acta. Molecular cell research. 1864(2)
Abnormal expression of claudin (CLDN) subtypes has been reported in various solid cancers. However, it is unknown which subtype plays a key role in the regulation of proliferation in cancer cells. The expression of CLDN3-5, 7, and 18 in human lung sq
Autor:
Ryo Watanabe, Yasuhiro Yamazaki, Satoshi Endo, Akira Ikari, Risa Akizuki, Saeko Taga, Shun Shimobaba, Toshiyuki Matsunaga, Junko Sugatani, Asami Hichino, Masahiko Yamaguchi
Publikováno v:
Biochimica et biophysica acta. 1863(6 Pt)
Abnormal expression of claudin subtypes has been reported in various cancers. However, the pathological role of each claudin has not been clarified in detail. Claudin-18 was absent in human non-small cell and small cell lung cancers, although it is e